| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −9.4× | −1.8× | |
| Price / Book | 3.1× | 2.1× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −12.0× | −1.6× | |
| EV / EBITDA | −9.3× | −1.1× | |
| Earnings yield | −10.6% | −14.1% | |
| Free cash flow yield | −8.3% | −9.6% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLY |
| $1,280.23 |
| −2.02% |
| $1.21T |
| 59.6× |
| 77.8% |
| +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.01 | −1.72% | $633.15B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $285.06 | −0.05% | $503.73B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $424.11 | −0.20% | $380.68B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.77 | −1.68% | $357.17B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.50 | −2.41% | $274.8B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $171.27 | −0.75% | $265.62B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $668.54 | −1.18% | $247.19B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $443.25 | −0.90% | $239.63B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.75 | −0.28% | $194.36B | 22.9× | 37.5% | +26.7% |
